Lecturer Department of Medical Microbiology MBChb.BaO(UK), Mc Med Micro (Lond) Dip L!"M (Lond) OU"L#$% &. Definition B. Pathophysiology C. Aetiological agents D. General clinical features %. Specific agents - 1. Clinical Features 2. Diagnosis 3. Treatment . Pre!ention &. Definition "eonatal inf # appearing $ithin first $%s of &irth ''''''''''''l'''''''''''' Congenital Postnatal ''''''''''''''''''''''''''' (ntrauterine Perinatal l )Transplacental* )Ascen+ing At +eli!ery* B. 'athophy(iology Foetus protecte+ &y, -aternal immunity )e.g. passi!e transfer of (gG* Foetal mem&ranes Foetus at ris%, (mmature immune system .rganogenesis )+epen+s on gestational age* /igh micro&e loa+ C.&etiological agent() Congenital Infections "O*C!
" o+opla(mo(i( O ther() ,aricella, B-., Li(teria,yphili( ,/onorrhoea, * ubella C ytomegalo0iru( ! erpe(,!epatiti( B ,C, !#, Perinatal infections -. e+ually)tran(mitted Neisseria gonorrhoeae Chlamydia trachomatis /uman papilloma!irus /erpes simple0 !irus /(1 )also &loo+-&orne* /epatitis 2 3 C4 )also &loo+-&orne* )4 not se0ually-transmitte+* 1. 2$ormal3 maternal flora Group 2 streptococcus )Strep. agalactiae* 5ntero&acteria6 e.g. E. coli D. /eneral Clinical 4eature( Common to "O*C! infections 4 lo$ &irth$eight 4 preterm +eli!ery 4 anaemia6 throm&ocytopaenia 4 hepatitis $ith 7aun+ice an+ hepatosplenomegaly 4 sei8ures 4 microcephaly 4 mental han+icap 4 encephalitis 4 failure to thri!e %. pecific agent(
Toxoplasma gondii .rganism, Proto8oa 6or+er 5ucocci+ia CAT, +efiniti!e host for repro transmitte+ &y oocysts in the faeces /9-A"S, ac:uire+ &y ingestion of contaminate+ cysts or meat6 lam& an+ por% )in*+irect contact $ith cat faeces )sporocyst * transfer $ithin organ transplant Pathology, Tropho8oite o&ligate intracellular parasite reticuloen+othelial cells mainly multiplies &inary fission6 cell +isruption an+ +eath Clinical features Gen , $i+e range -ost asymptomatic. mil+6 self-limiting6 non-specific (- syn+rome Disseminate+ organ +amage &rain6 eyes6 muscles6 li!er6 an+ lungs immunocompromise+ #se!ere 6 A(DS -focal neurological +efect space-occupying lesion Cong 1;< se!ere +amage at or shortly after &irth neurological +amage cere&ral calcification6 hy+rocephalus chorioretinitis. =; - >;< months or years &ilateral !isual loss +ue to chorioretinitis 6post u!eitis hepatosplenomegaly 5pi+emiology of Congenital To0oplasmosis pregnant mothers primary infection 1 - ? per 1;;; in the 9@ fetal +amage ris% if infect earlier !ertical transmission ris% less 33 < symptomatic +isease 1 in 1;6;;; increase+ /(1 infection countries $here ra$ meat is eaten Diagnosis - may &e +ifficult -aternal (g-6 serocon!ersion (gG Cor+ (g-A (gA PCBA culture of amniotic flui+ Pre!ention Antenatal screening in some countries Treat infecte+ mother 3 &a&y $ith spiramycin or pyrimethamine-sulpha+ia8ine Herpesviruses 5n!elope+ +ou&le stran+e+ D"A !iruses. Three su&families, # &lphaherpe(0iru(e( ) !,)-, !,)1, ,5, # Betaherpe(0iru(e( ) CM,, !!,)6, !!,)7 # /ammaherpe(0iru(e( ) %B,, !!,)8 Features- # Catent or persistent infection follo$ing primary infection # Beacti!ation +uring immunosurpression # more serious in immunocompromise+ patients. o ,aricella 5o(ter ,iru( /erpes!iruses su&family alphaherpes!irus +s D"A en!elope+ !irus Genome si8e Serotype 1 antigenictype only some cross reaction $ith /S1 /en clinical feature( Primary infection !aricella )chic%enpo0* Secon+ary /erpes 8oster )shingles* Pregnancy Congenital herpes "eonatal herpes Transmission Bespiratory +roplets6 !esicles contact (ncu&ation perio+ 1-21 +ays (nfectious perio+ from +ays &efore the appearance of the rash until all lesions ha!e sca&&e+ o!er )appro0imately one $ee%*. Pregnancy 3 per 1;;; $omen ) 9@ * (mmune- >;< $omen ha!e anti&o+ies to !aricella 8oster !irus also protecte+ if secon+ary occurs "onimmune potentially +angerous +isease fetal 3maternal mor&i+ity high fi!e times more li%ely to &e fatal than in non-pregnant $omen 1< +e!elop pulmonary in!ol!ement esp smo%ing Fetal outcome -ost healthy (n utero &reach -Congenital Perinatal-"eonatal Congenital A fetal !aricella syn+rome Bare $hen infection occurs early Bis% ;.D< if 2-12 $ee%s preg E 1.< if 12-2= $ee%s ;< if from 2= $ee%s on ;.>1< o!erall ris% first 2; $ee%s Clin features s%in lossAscarring C"S impairment )e.g. hypotonia* lim& hypoplasia Aparesis C2F microcephaly6 ophthalmological a&normalities. "eonatal Cate stages of pregnancy cross the placenta (mmunity sufficient if rash in mother occurs G1 $ee% &efore +eli!ery (nsufficient if mother ill D +ays &efore until = hrs after +eli!ery Clin features !ary from a mil+ +isease to a fatal +isseminate+ infection. Pre!ention 3Treatment For suscepti&le mother, Ci!e attenuate+ !accine )&efore pregnancy* 1H immunoglo&ulin )after e0posure* infection control precautions For ne$&orn 1H immunoglo&ulin if mother gets c-po0 last I +ays of pregnancy or the first 1 +ays after +eli!ery. infection control precautions Treatment (f acute acyclo!ir Ca&oratory Diagnosis Barely re:uire+ for primary characteristic clin features 1irus (solation 2-3 $ee%s for a results. Serology (gG past infection an+ immunity (g- recent primary infection. Direct +etection 5- !esicle flui+s cannot +istinguish /S1 an+ 1H1. (F on s%in scrappings can +istinguish PCB Parvovirus !" Properties na%e+ icosahe+ral ss D"A Antigenically +istinct from the !iruses foun+ in faeces6 BA-1 an+ other par!o!iruses 5pi+emiology3 Pathogenesis 21> present throughout the year .ut&rea%s in temperate climates out&rea%s more in the spring an+ summer aroun+ primary schools ;< of pupils may &e infecte+. Commonest amongst - 1; yr ol+s. 2y a+ulthoo+ ?;< population seropositi!e. Transmission Bespiratory sprea+ usual route 2loo+&orne occur Clinical features Pregnancy not associate+ $ith increase+ ris% of fetal malformation 29T fetal loss ma7ority of pregnancies procee+ to term $ith +eli!ery of normal infants infection in first trimester D - 1;< fetal loss. (nfection in secon+ trimester 12.D<. /y+rops fetalis seen in ne$&orn $ith secon+ an+ thir+ trimester infection -aternal infection occurs 2 to 12 $ee%s prior to +iagnosis Se!ere anaemia lea+s to heart failure6 effusions6 +iffuse oe+ema J2; $ee%s gestation Clinical features 5rythema infectiosum Chronic haemolytic anaemias Aplastic crisis (mmunocompromise+ persistent infection in patients Diagnosis Differential +iagnosis all +iseases of maculopapular rash eg. ru&ella6 entero!iruses6 ar&o!iruses6 streptococcal infection6 allergy. 1irus Detection +etection of the !irus in fetal &loo+ samples or autopsy material +irect or immune 5-. B(A or D"A-D"A hy&ri+i8ation6 PCB Anti&o+y Detection 5C(SA or B(A. Kanti&o+y captureK +etection of either )i* 21>-specific (g- or )ii* a rising titre of 21> specific (gG. 21> specific (g- may &e +etecte+ in such tests up to 3 months after the onset of symptoms. 21> (gG lasts longer &ut this anti&o+y is not detectable lifelong follo$ing infection. patients $ith no +etecta&le (gG may ha!e e0perience+ pre!ious 21> infection Treatment During pregnancy Supporti!e only pregnancy shoul+ &e allo$e+ to procee+ $ith monitoring. At +eli!ery e0amination of the cor+ &loo+ for 21> (g-. Chil+ follo$e+ up for +elaye+ se:uelae (mmunocompromise+ persistent 21> infection only specific treatment a+ministration of /"(G Pre!ention (nfection control /"(G Treatment erythema infectiosum rarely necessary6syptomatic chronic haemolytic anaemias transfusion of erythocytes until a satisfactory /& le!el Pre!ention (nf control Lis#eria mono$%#ogenes GPB6 L-haemolytic -other infecte+ &y, contact $ith animals6 soil eating contaminate+ foo+ or unpasteurise+ mil%A soft cheese -other mil+6 flu-li%e illness 2acteraemia may cause, a&ortion premature la&our neonatal sepsisA meningitis Treatment, ampicillin EA- gentamicin Ru&ella Properties "on-arthropo+-&orne toga!irus Genus Bu&i!irus only mem&er 5n!elope+ !irus6 ?;nm in +iameter6 nucleocapsi+ 33nm symmetry icosahe+ral &ut !irus particle has a pleomorphic appearance. Genome ssB"A E!e ;S B"A consists of 3 structural proteinsM 51 52 mem&rane &oun+ glycoproteins6 an+ C capsi+ protein 51 has ? +istinct antigenic +eterminantsM associate+ $ith haemagglutination6 an+ 2 $ith neutrali8ation serotype ."5 Gro$th in a $i+e range of cell lines. (t ( n+uces a CP5 only in continuous cell lines such as B@13 )ra&&it %i+ney* an+ 1ero *ubella %pidemiology Forl+$i+e 2efore immunisation .ut&rea%s ten+ to occur Spring an+ Summer. uncommon in preschool chil+ren &ut out&rea%s (nfection in!ol!ing school chil+ren an+ young a+ults $ere common. D;< of 1; year ol+s ha!e ru&ella anti&o+ies. =;< of $omen of chil+&earing age immune Pro&lem upta%e *ubella Pathogenesis (ncu&ation perio+ 13 to 2; +ays Transmission &y respiratory route. Beinfection "atural infection high le!el of protection from reinfection. can occur $hich is generally asymptomatic. Beinfection in pregnancy minimal ris% to the fetus Congenital infection !irus enters fetus +uring maternal !iraemic phase through the placenta. rapi+ +eath of some cells an+ persistent !iral infection in others +amage to all germ layers Chromosomal a&errations re+uce+ cell +i!ision 1irus high if the mother infecte+ +uring first trimester. (mmune sytem immature !irus persists throughout the gestation can &e isolate+ from most organs6secretions.The mechanism of !irus persistence +efects in cell- me+iate+ immunity *ubella Pathogenesis First trimester ris% of ma7or malformations 1;< to D<
ris% greatest first = $ee%s of pregnancy )/ansha$ et al 1>=D* critical phase of organogenesis. Car+iac an+ eye +efects are more li%ely 13 an+ 1? $ee%s Deafness usually sole manifestation 1? to 2; $ee%s of gestation retinopathy an+ hearing +efects *ubella Clinical Features Bash !iraemia occurs 3 !irus +isseminates throughout the &o+y. (n chil+ren rash onset a&rupt. (n a+ults pro+romal phase for a +ay or t$o rash +e!elops. Typically maculopapular rash first appears on face sprea+s to the trun% an+ lim&s. J 3 +ays. immunopathological mechanism Cympha+enopathy a $ee% &efore rash an+ 2 $ee%s after the rash has gone *ubella Clinical Features Noint in!ol!ement is the commonest complication an+ occurs in up to ?;< of a+ult females. The fingers6 $rists %nees an+ an%les are most fre:uently affecte+. The arthralgia lasts usually 3- +ays. Arthralgia is rare in males an+ prepu&ertal females. An 5ncephalitis +e!elops in 1 A 1;;;; &ut the prognosis is goo+. Trom&ocytopenic purpura may present as purpuric rash6 epita0is6 haematuria an+ G( &lee+ing. (n 2D< the infection is su&clinical.. *ubella Clinical Features Congenital ru&ella syn+rome )CBS* "ran(ient9) (9GB6 throm&ocytopenic purpura6 hepatoslenomegaly an+ haemolytic anaemia. first fe$ $ee%s of life not permanent . Transient &one lesions in 2;< 2D< ha!e a meningoencephalitis E-lea!e neurological se:uelae. Naun+ice common De0elopmental9) Sensorineural +eafness6 mental retar+ation6 insulin-+epen+ent +ia&etes. (DD- common manifestation of CBS ) up to 2;<*. Delaye+ onset a+olescence or a+ulthoo+. Autoimmune mechanisms may &e in!ol!e+. may ta%e months &efore &ecome apparent &ut persists permanently. 2et$een 3 - 12 months late onset +iseaseK. some infants +e!elop a ru&&elliform rash6 persistent +iarrhoea an+ pneumonitis referre+ to as high mortality. 'ermanent9) /eart +efects )patent +uctus6 1SD6 pulmonary !al!e stenosis*6 eye +efects )retinopathy6 cataract6 microopthalmia6 glaucoma6 se!ere myopia*6 C"S +efects )microcephaly6 psychomotor retar+ation*. *ubella Clinical Features Congenital ru&ella syn+rome )CBS* *ubella La& +iagnosis Difficult clinically Serology -ain +iagnosis of ru&ella infection.SB/6 5C(SA A recent ru&ella infection can &e +iagnose+ &y 1* +etection of ru&ella-specific (g-6 )2* rising titres of anti&o+y in /A( an+ 5C(SA tests )3* serocon!ersion /istory 5ssential accurate information relating +ate an+ time of e0posure6 onset of illness. A history of pre!ious ru&ella !accination Epre!ious results of ru&ella screening tests. Pregnant $omen #&loo+ collectec asap 1irus isolation Cess use+ no$ from nasopharyngeal secretions ) an+ occasionally from faeces an+ urine * I +ays &efore an+ up to I +ays after rash. *ubella Diagnosis congenitally ac:uire+ ru&ella Presence of ru&ella (g- in cor+ &loo+ serum samples ta%en infancy Detection of ru&ella anti&o+ies at a time $hen maternal anti&o+ies shoul+ ha!e +isappeare+ )appro0.? months of age* (solation of ru&ella !irus from infecte+ infants in the first fe$ months of life Prenatal +iagnosis Amniotic flui+ fetoscopy (g- *ubella Treatment an+ Pre!ention Treatment Supporti!e 6 counselling in pregnancy Pre!ention 1accination Passi!e immunisation /"(G +oes not pre!ent infection in non-immune contacts may re+uce the li%elihoo+ of clinical symptoms may re+uce the le!el of maternal !iraemia an+ ris% to fetus.
Antenatal screening (nfection control C%#omegalovirus Properties /erpes!iruses su&family &etaherpes!irus +s D"A en!elope+ !irus Cytomegalo!irus 5pi+emiology (nci+ence De!elope+ countries # higher stan+ar+ of hygiene6 # ;< of a+olescents are infecte+ # I;< of the population is infecte+ De!eloping countries # >;< of people infecte+ Transmission 1ery succesful 1ertical an+ hori8ontal 2loo+ an+ pro+ucts (n utero6 peri 3postnatal Perinatal 1; times more common 2 - 1;< of infants are infecte+ &y the age of ? months $orl+$i+e 1-2< li!e &irths are infecte+M up to 1;< of these ha!e symptoms ;< foetal infection if maternal primary infection Cytomegalo!irus Pathogenesis Cife long Beacti!ation # Perio+ically # immunocompromise+ esp # infectious !irions appear in the urine an+ the sali!a # Bare lea+ing to !ertical transmission ;.1D - 1<. Perinatal infection # mainly through infecte+ genital secretions or &reast mil%. Postnatal infection # mainly occurs through sali!a. # Se0ual transmission may occur as $ell as through # &loo+ an+ &loo+ pro+ucts an+ transplante+ organ. Cytomegalo!irus Clinical 1; - 2;< are symptomatic at &irth =; - >;< are asymptomatic at &irth &ut later e0hi&it, mental han+icap !isual impairment progressi!e hearing loss +elaye+ psychomotor retar+ation intrauterine infection less li%ely to &e suspecte+ Congenital infection # cytomegalic inclusion +isease Perinatal infection usually asymptomatic Postnatal infection # usually asymptomatic. minority ifectious mononucleosis (mmunocompromise+ A(DS 3 transplant recipients an+ A(DS se!ere C-1 +isease pneumonitis6 retinitis6 colitis6 an+ encephalopathy. Beacti!ation or reinfection usually asymptomatic e0cept in immunocompromise+ patients Cytomegalo!irus Cytomegalic (nclusion Disease C"S a&normalities microcephaly6 mental retar+ation6 spasticity6 epilepsy6 peri!entricular calcification. 5ye - choroi+oretinitis an+ optic atrophy 5ar # sensorineural +eafness Ci!er - hepatosplenomegaly an+ 7aun+ice Cung # pneumonitis /eart # myocar+itis 2loo+ Throm&ocytopenic purpura6 /aemolytic anaemia Cate se:uelae in in+i!i+uals asymptomatic at &irth hearing +efects an+ re+uce+ intelligence. Cytomegalo!irus Ca&oratory Diagnosis 1irus (solation gol+ stan+ar+ &ut up to $ee%s rapi+ culture metho+s eg D5AFF test 2-= hours. 2a&y- from urine 1-3 $ee%s Direct +etection /istology C-1 inclusion anti&o+ies Apresence of C-1 antigens. Co$ sensiti!ity pp?D C-1 antigenaemia test in immunocompromise+ patients. PCB for C-1-D"A 6 interpretation pro&s 2a&y-urine 1-3 $ee%s Serology -um (gG anti&o+y past infection. (g- anti&o+y in+icati!e of primary infection Also reacti!ation in immuno compromise+ patients 2a&y 2loo+ (g- in first 3 $ee%s of life Cytomegalo!irus Treatment 3Pre!ention Treatment Supporti!e only unless immunocompromise+ ganciclo!ir6 forscarnet6 an+ ci+ofo!ir. Congenital infections 9nless primary not usually possi&le to +etect counselling Peri an+ post natal - "ot nec
Pre!ention no relia&le C-1 !accine a!aila&le. &est &y re+ucing e0posure to to++lerOs urine &loo+ for +onation to infants shoul+ &e from C-1-negati!e +onors. %+po(ure of foetu( to infection: outcome( Fhat +o $e +o to pre!ent foetal an+ neonatal infectionP 1accinate all potential mothers Tetanus Bu&ella /epatitis 2 1H1 )in 9SA6 Napan Antenatal screening of pregnant mothers /(1 /epatitis 2 surface antigen Syphilis Bu&ella )not +one in -alaysia* To0oplasma )selecte+ countries only6 e.g. France* Group 2 streptococcus )selecte+ countries only6 e.g. 9SA* Fhat +o $e +o to pre!ent foetal an+ neonatal infectionP (n some infections in pregnant mothers6 there are inter!entions to re+uce ris% of foetalAneonatal infection, Maternal infection Maternal inter0ention $eonatal prophylactic inter0ention /(1 Antiretro!iral +rugs6 caesarean6 no &reast-fee+ing Antiretro!iral +rugs /epatitis 2 Screening /ep status in high ris% groups (1D9 6 en+emic Acti!e immunisation EA- immunoglo&ulin 1H1 (mmunoglo&ulin )if early pregnancy* (mmunoglo&ulin )if near +eli!ery* /S1-1 3 2 Caesarean Aciclo!ir Syphilis Penicillin Penicillin To0oplasma Anti-To0oplasma +rugs Anti-To0oplasma +rugs Group 2 strep Penicillin .&ser!e EA- penicillin Than% you Q